FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry, namely to an agent exhibiting anticoagulation activity. A humic agent exhibiting anticoagulation activity, containing water and humic substances produced from humic-containing raw materials selected from the group including leonardite, lignin, coal, peat and/or sapropel by means of ultrasonic dispersion of pre-ground raw materials mixed with water at a temperature of 30 to 80°C and a pressure of 0.05 to 0.8 MPa, followed by cooling the solution to room temperature and diluting with water until reaching a content of humic substances of 1 to 20% wt., wherein the humic substances include humic and fulvic acids and salts thereof, as well as hydroquinone in an amount not exceeding 3% wt. of the weight of the humic substances. An application of the humic agent for reducing the blood viscosity and lowering the probability of development of blood clots.
EFFECT: above agent exhibits a pronounced anticoagulation activity, reduces the blood viscosity and lowers the probability of development of blood clots.
2 cl, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTI-INFLAMMATORY HUMIC AGENT | 2020 |
|
RU2756363C1 |
DETOXIFYING HUMIC AGENT | 2020 |
|
RU2756354C1 |
ANTIVIRAL HUMIC AGENT | 2020 |
|
RU2753609C1 |
ANTIBACTERIAL HUMIC AGENT | 2020 |
|
RU2753606C1 |
IMMUNOMODULATING HUMIC AGENT | 2020 |
|
RU2756353C1 |
HEPATOPROTECTIVE HUMIC AGENT | 2021 |
|
RU2763761C1 |
METHOD OF PRODUCING HUMIC SUBSTANCE EXTRACT | 2019 |
|
RU2720308C1 |
ADAPTOGENIC HUMIC AGENT | 2021 |
|
RU2775079C1 |
ANTICOAGULANT AGENT BASED ON HUMIC ACIDS OF LOW-MINERALIZED SILT SULFIDE MUD | 2022 |
|
RU2807928C1 |
HUMIC PREPARATION AND METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2717659C1 |
Authors
Dates
2021-09-29—Published
2020-10-16—Filed